#Cardiology #ASCVD #ClinicalResearch #CardiovascularRisk #Obesity #EvidenceBasedMedicine #PrecisionMedicine Evolocumab can help attenuate the elevated risk of major adverse cardiovascular events that individuals with obesity and atherosclerotic cardiovascular disease (ASCVD) face, according to a prespecified analysis from the FOURIER trial published in #JACC
This treatment is designed to enhance athletic performance and speed up recovery by replenishing essential vitamins, minerals, amino acids, and electrolytes
Women experiencing significant distress related to body image or weight should be encouraged to discuss mental health concerns with their GP or health visitor
An apple with macadamia nut butter
At Centra Internal Medicine, we have seen that patients using semaglutide under our supervision often achieve greater weight loss compared to lifestyle changes alone
Press, lift, move 1 to 2mm, press, lift